risks of using glp 1 💡 New research suggests a possible side effect GLP-1 medications. The study found: ✔️ 48% higher risk of smell or taste disorders ✔️ 81% higher risk of smell changes ✔️ 52% Is GLP-1 the Same as

Originally discovered in the 1970s, DSIP is a neuropeptide linked to the regulation of sleep cycles, stress response, and even hormone release

Saxenda (liraglutide) is a GLP-1 receptor agonist used for weight management in adults and adolescents with obesity or overweight with comorbidities

In the UK, the NHS and the Environment Agency provide guidance on the disposal of medicines and medical waste

Intended for adult use

Research published in major diabetes and obesity journals demonstrates that GLP-1 therapy produces weight loss independent of extreme calorie counting

For CT, maxadilan, and CGRP, a disulfide linkage precludes helix propagation to the N-terminus, while for UCN1 and CRF the presence of proline residues near the N-terminus discourages local -helicity